Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-137782

Chief Executive Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-08-17 Exercise or conversion : show line 1 in the form +20,000 $1.00 $20,000 31,490 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2016-08-17 Exercise or conversion : show line 2 in the form Options to purchase common stock −20,000 $1.00 $20,000 $1.00 2024-04-11 20,000 292,728 D
Loading xslF345X03/doc4.xml…